Kahira Pharmaceuticals & Chemical Industries Company (EGX: CPCI)

EGX: CPCI Cash Flow Statement

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Net Income	261.28	246.11	97.09	165.74	124.3	109.14
Depreciation & Amortization	19.84	19.84	15.94	-	-	0.65
Other Amortization	0.01	0.01	0.01	-	-	-
Other Operating Activities	3.53	-3.08	-24.52	-113.92	37.95	-131.75
Operating Cash Flow	284.67	262.89	88.53	51.83	162.25	-21.96
Operating Cash Flow Growth	221.56%	196.96%	70.82%	-68.06%	-	-
Capital Expenditures	-265.43	-243.54	-79.07	-17.31	-23.68	-8.34
Sale of Property, Plant & Equipment	-	-	0.08	0	0.04	-
Investment in Securities	-0.02	-0.84	-	15.86	-14.11	14.47
Other Investing Activities	16.74	12.8	2.85	4.94	2.62	2.28
Investing Cash Flow	-248.71	-231.58	-76.14	3.49	-35.13	8.41
Long-Term Debt Issued	-	133.88	144.31	-	-	-
Long-Term Debt Repaid	-	-50.76	-28.36	-	-	-
Net Debt Issued (Repaid)	12.28	83.12	115.95	-	-	-
Common Dividends Paid	-85.53	-85.53	-100.82	-75.2	-77.73	-54.95
Financing Cash Flow	-73.25	-2.41	15.13	-75.2	-77.73	-54.95
Miscellaneous Cash Flow Adjustments	0	-	-	-	-	-
Net Cash Flow	-37.29	28.9	27.51	-19.89	49.39	-68.5
Free Cash Flow	19.24	19.35	9.45	34.52	138.57	-30.3
Free Cash Flow Growth	103.51%	104.69%	-72.61%	-75.09%	-	-
Free Cash Flow Margin	1.33%	1.42%	0.94%	3.10%	13.05%	-3.00%
Free Cash Flow Per Share	1.29	1.30	0.63	2.31	9.28	-2.03
Cash Interest Paid	20.21	20.21	5.85	-	-	-
Cash Income Tax Paid	45.89	45.89	73.12	51.33	36.22	36.35
Levered Free Cash Flow	-70.6	-55.03	57.94	-20.17	97.35	-51.72
Unlevered Free Cash Flow	-58.81	-43.19	60.12	-20.17	97.35	-51.72
Change in Net Working Capital	2.21	-1.94	-75.27	122.91	-23.32	130.76

Source: S&P Capital IQ. Standard template. Financial Sources.